Poly Medicure P/B Ratio
Poly Medicure (POLYMED) P/B ratio is 4.91 (High), book value per share ₹542.35 vs Healthcare average P/B of -1.0 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see POLYMED stock live price.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
POLYMED P/B Ratio — Valuation Insights & Book Value Analysis
Poly Medicure price-to-book ratio interpretation, valuation status and historical context — current P/B 4.91 (High).
- Stock appears overvalued with PB of 4.91, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -1.0
Poly Medicure P/B Ratio Historical Trend
POLYMED annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Browse Poly Medicure annual reports for revenue, profit, balance sheet and cash flow data.
POLYMED Historical P/B Ratio — Book Value Per Share & Year-End Price
Poly Medicure annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 3.27 | ₹542.35 | ₹1773.70 | ₹2,766 | High |
| 2024 | 8.54 | ₹306.25 | ₹2615.25 | ₹1,470 | High |
| 2023 | 5.76 | ₹258.75 | ₹1489.90 | ₹1,242 | High |
| 2022 | 3.96 | ₹226.67 | ₹897.85 | ₹1,088 | High |
| 2021 | 4.76 | ₹201.25 | ₹957.95 | ₹966 | High |
POLYMED vs Healthcare Peers — P/B Ratio Comparison
Poly Medicure P/B 4.91 vs Healthcare average -1.0, median 0.62 — range -36.63–1.05.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -36.63 | ₹28 | Low |
| Sun Pharma Advanced Rese… | SPARC | -13.83 | ₹4,744 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.35 | ₹76 | Low |
| Parmax Pharma | PARMAX | -2.09 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |